TGF-b adalah penghambat proliferasi yang kuat dalam sel-sel epitel normal
dalam berbagai jaringan. Dalam model kanker prostat, ada bukti bahwa sel-sel
ganas telah lolos dari efek penghambat pertumbuhan TGF-b Sel Epitel
berkontribusi terhadap Pengembangan BPH melalui Interaksi Sel Epitel-Stromal
Studi klinis menunjukkan kemanjuran dutasteride yang lebih baik daripada
finasteride dalam meredakan BPH.3
Salah satu efek penggunaan finasterid akan mengurangi ekspresi dari VEGF
(vascular endothelial growth factors) sehingga secara tidak langsung dapat
mengurangi ukuran prostat.9
DAFTAR PUSTAKA
1. Hoda SA, Hoda RS. Rosai and Ackerman’s Surgical Pathology.
Advances in Anatomic Pathology. 2004;11(6):323.
2. Cunha GR, Hom YK. Role of mesenchymal-epithelial interactions in
mammary gland development. J Mammary Gland Biol Neoplasia.
1996;1(1):21-35. doi:10.1007/BF02096300
3. Arianto E, Pratama ARH, Palgunadi. Patogenesis molekul dan selular
hiperplasia prostatik jinak.Tinjauan Literatur.
4. Chughtai B, Lee R, Te Alexis. Role Of Inflammasion In Benign Prostatic
Hyperplasia. Disease State Review Department of Urology Well Cornell
Medical College. 2011
5. Kouji I, Atsushi M. Androgen Receptor Roles in the Development of
Benign Prostate Hyperplasia. The American Journal of Pathology. 2013
6. Keith Lee, Donna M. Molecular and Cellular Pathogenesis of Benign
Prostatic Hyperplasia. American Urological Association. 2004
7. Samarinas M, Gravas S. The Relationship Between Inflammation and
LUTS/BPH. University Hostital of Larissa.2018
8. Culley C, Roger R. The Role of Dihydrotestosterone in Benign Prostatic
Hyperplasia.Elsevier. 2003
9. Gerald A, Nicholas B. Dihydrotestosterone and the Prostate: the Scientific
Rationale for 5-alfa reductase Inhibitors in the Treatment of Benign
Prostatic Hyperplasia. The Journal of Urology. American Urological
Association. 2004